Low Dose Naltrexone (LDN) & Chronic Pain

Pain is real whether it is felt immediately after a traumatic event or in the absence of apparent tissue damage on imaging. We now know through pain neuroscience research and understanding the biopsychosocial approach to chronic pain that patients’ perceived experiences of pain are unique to them and are entirely valid. On the show today, we have Dr. Neel Mehta, MD. He is the Division Chief of the Weill Cornell Pain Management Center and an Associate Professor of Clinical Anesthesiology at Weill Cornell Medical College. He also leads research on Low Dose Naltrexone (LDN).We chat about the uses, benefits, and side effects of LDN and how it can be used with patients with hypermobility, fibromyalgia, interstitial cystitis, and more. Dr. Mehta discusses how little research has been done on the drug and how he hopes to delve deeper into it to maximize patient outcomes. Dr. Mehta also serves as a Co-Director of Och Spine at Weill Cornell Medicine.  He is the Immediate-Past President of the Eastern Pain Association and Secretary of the New York Society of Interventional Pain Physicians. Dr. Mehta completed his fellowship in Interventional Pain Medicine in the Tri-Institutional Pain Medicine Fellowship at NewYork-Presbyterian Hospital/Weill Cornell Medical Center, Hospital for Special Surgery, and Memorial-Sloan Kettering Cancer Center. Connect with him and his team:646-962-7246weillcornell.org/services/pain-management@wcmpain